SLC25A31 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A32 | Solute carrier family 25 (mitochondrial folate carrier), member 32 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A33 | Solute carrier family 25 (pyrimidine nucleotide carrier), member 33 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC25A34 | Solute carrier family 25, member 34 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A35 | Solute carrier family 25, member 35 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC25A36 | Solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A37 | Solute carrier family 25 (mitochondrial iron transporter), member 37 | Mitochondrial proteins Transporters
| | | | | Expressed in all |
SLC25A38 | Solute carrier family 25, member 38 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A39 | Solute carrier family 25, member 39 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A4 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Disease related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC25A40 | Solute carrier family 25, member 40 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A41 | Solute carrier family 25, member 41 | Mitochondrial proteins Transporters
| | | | | Tissue enriched |
SLC25A42 | Solute carrier family 25, member 42 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A43 | Solute carrier family 25, member 43 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A44 | Solute carrier family 25, member 44 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A45 | Solute carrier family 25, member 45 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A46 | Solute carrier family 25, member 46 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A47 | Solute carrier family 25, member 47 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A48 | Solute carrier family 25, member 48 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A5 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A51 | Solute carrier family 25, member 51 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A52 | Solute carrier family 25, member 52 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A6 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A1 | Solute carrier family 26 (anion exchanger), member 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC26A10 | Solute carrier family 26, member 10 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC26A11 | Solute carrier family 26 (anion exchanger), member 11 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A2 | Solute carrier family 26 (anion exchanger), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A4 | Solute carrier family 26 (anion exchanger), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC26A5 | Solute carrier family 26 (anion exchanger), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A8 | Solute carrier family 26 (anion exchanger), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC26A9 | Solute carrier family 26 (anion exchanger), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A3 | Solute carrier family 28 (concentrative nucleoside transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC29A1 | Solute carrier family 29 (equilibrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC29A2 | Solute carrier family 29 (equilibrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC29A3 | Solute carrier family 29 (equilibrative nucleoside transporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A10 | Solute carrier family 2 (facilitated glucose transporter), member 10 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC2A11 | Solute carrier family 2 (facilitated glucose transporter), member 11 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A12 | Solute carrier family 2 (facilitated glucose transporter), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A13 | Solute carrier family 2 (facilitated glucose transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A6 | Solute carrier family 2 (facilitated glucose transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Mixed |